Patents
Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
05/2006
05/03/2006EP1651162A2 Improved cytotoxic agents comprising new maytansinoids
05/03/2006EP1505930A4 Drug-delivery endovascular stent and method for treating restenosis
05/03/2006EP1495007A4 Process for preparing heteroaryl and unsaturated heterocycloalkylmagnesium reagents and uses
05/03/2006EP1139755B1 Method for treatment of bacterial infections with once or twice-weekly administered rifalazil
05/03/2006CN1768066A Crystallization and purification of macrolides
05/03/2006CN1765900A Spiro oxazone derivative containing naphthalimide unit
05/03/2006CN1765893A Process for the preparation of arylethanoldiamines useful as agonists of the beta-3-adrenoceptor
05/03/2006CN1765886A Process for the preparation of arylethanoldiamines useful as agonists of the beta-3-adrenoceptor
05/02/2006US7038043 acetylation of indolocarbazoles forming furanosylated indolocarbazole ; reacting a diazo compound with biindole compound
05/02/2006US7037921 Compounds and methods for inhibiting MRP1
05/02/2006US7036723 Card package production system card with insertion prevention and method
04/2006
04/27/2006WO2006044869A1 Synthesis of imidazooxazole and imidazothiazole inhibitors of p38 map kinase
04/27/2006WO2006044402A1 Furazano `3, 4-b ! pyrazynes and their use as anti-tumor agents
04/27/2006WO2006043090A1 Imidazo[4,5-b]pyridin-2-one and oxazolo[4,5-b]pyridin-2-one compounds and analogs thereof as therapeutic compounds
04/27/2006US20060089397 Synthetic diazonamides
04/27/2006US20060089370 Thieno-pyrimidine compounds having fungicidal activity
04/27/2006US20060089357 Novel compounds and compositions as cathepsin inhibitors
04/27/2006CA2584651A1 Imidazo[4,5-b]pyridin-2-one and oxazolo[4,5-b]pyridin-2-one compounds and analogs thereof as therapeutic compounds
04/27/2006CA2584368A1 Synthesis of imidazooxazole and imidazothiazole inhibitors of p38 map kinase
04/26/2006EP1650211A1 Process for preparing imidazopyran derivatives
04/26/2006EP1648905A1 Thienopyridine and furopyridine kinase inhibitors
04/26/2006EP1648898A1 Hetaryl-substituted pyrazolidindione derivatives with pesticidal characteristics
04/26/2006EP1648893A1 Nicotine addiction reducing heteroaryl fused azapolycyclic compounds
04/26/2006EP1648872A2 Aryl fused azapolycyclic compounds
04/26/2006EP1648871A1 Piperidine or 8-aza-bicyclo 3.2.1 oct-3-yl derivatives useful as modulators of chemokine receptor activity
04/26/2006EP1648870A2 Sulfonic acid derivatives of polycyclic dyes used for analytical applications
04/26/2006EP1648564A1 Cyanoamide compounds useful as malonyl-coa decarboxylase inhibitors
04/26/2006CN1253458C Process for preparing substance GM-95
04/25/2006US7034131 Antibody therapy; immobilization
04/25/2006US7033604 Composition for topical administration
04/20/2006WO2006004658A3 Furanopyrimidines
04/20/2006WO2005115398A3 Hiv integrase inhibitors
04/20/2006WO2005111039A3 Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase
04/20/2006US20060084805 coupling 3-(piperidin-1-yl)propan-1-amine with intermediate methyl 6,7-dihydro-4-hydroxy-7-isopropyl-6-oxothieno-[2,3-b]pyridine-5-carboxylate to form 6,7-dihydro-4-hydroxy-7-isobutyl-6-oxo-N-(3-(piperidin-1-yl)propyl)thieno[2,3-b]pyridine-5-carboxamide
04/20/2006US20060084803 Bicyclic pyridine and pyrimidine P38 kinase inhibitors
04/20/2006US20060084643 6-Fluoro-10-[3-(2-methoxy-ethyl)-4-methyl-piperazin-1-yl]-2-methyl-4H-3-thia-4,9-diaza-benzo[f]azulene; dopamine D2 and serotonin receptor anatagonist; neuroleptic agent, antidepressnt; psychological, bipolar disorders, psychosis, schizophrenia, acute mania
04/20/2006US20060084141 Biosynthetic gene cluster for the maytansinoid antitumor agent ansamitocin
04/19/2006EP1646635A1 Cci-779 isomer c
04/19/2006EP1646634A1 Use of rapamycin and rapamycin derivatives for the treatment of bone loss
04/19/2006EP1537112B1 Condensed pyridines and pyrimidines with tie2 (tek) activity
04/19/2006EP1212330B1 Androgen receptor modulator compounds and methods
04/19/2006EP1044197B1 Piperidinyl-substituted pyridylalkane, alkene and alkyne carboxamides as cytostatic agents and immunosuppressants
04/18/2006US7030240 Piperidinylamino-thieno[2,3-d] pyrimidine compounds
04/18/2006US7030116 Compounds and compositions as cathepsin inhibitors
04/18/2006US7030107 nitrogen compounds such as 5-[3,5-bis(trifluoromethyl)benzyl]-6-oxo-7-phenyl-9-[4-(pyrrolidine-1-yl)piperidine-1-yl]-2,3,4,5-tetrahydro-6H-pyrido[2,3-b][1,5]oxazocine, used as neurokinin inhibitors for prophylaxis of urogenital disorders; side effect reduction
04/13/2006WO2006039619A1 Hydroxy amide acetals and their use in coatings
04/13/2006WO2006039618A1 Polymeric/oligomeric methacrylate functionalized amide acetals in coatings
04/13/2006WO2006038972A1 Cci-779 derivatives and methods of making same
04/13/2006WO2006016167A3 17-desmethylrapamycin and analogues thereof, methods for their roduction and their use as immunosupressants, anticancer agents, antifungal agents, etc.
04/13/2006WO2005118549A3 Compounds having affinity for dopamine d3 receptor and uses thereof
04/13/2006WO2005110416A3 4,5-disubstituted-2-aryl pyrimidines
04/13/2006US20060079707 Cyclization by reacting 4-(2-CHLORO-4-TRIFLUOROMETHYL-PHENYL)-4-CYANO-BUT-3-ENOIC ACID METHYL ESTER in the presence of a palladium catalyst and a base; chemical intermediates for preparing 10-AZA-TRICYCLO[6.3.1.02,7] drugs; bind nicotinic acetylcholine receptor, modulate cholinergic function
04/13/2006US20060079677 Novel tricyclic azepine derivatives, method for production thereof and pharmaceutical compositions comprising the same
04/13/2006US20060079676 washing, crystallizing
04/13/2006US20060079549 Administering a stimulantfor the endogenous production/ release of somatotropins; 3-((1-(2-aminoprop-2-yl)carbonylamino-),2-(phenylmethoxymethyl-)ethyl-),5-(morpholino-carbonyloxymethyl-)-5,6,7,8-tetrahydro-1,2,4-triazolo(4,3-)pyridine; osteoporosis; obesity;improving bone densisty, muscle mass/strength
04/13/2006US20060079548 Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use
04/13/2006US20060079547 Thienopyridinone compounds and methods of treatment
04/13/2006US20060079520 Sulfonamide peri-substituted bicyclics for occlusive artery disease
04/13/2006US20060079517 Reverse-turn mimetics and methods relating thereto
04/13/2006US20060079498 ((2S,4S)-4-(4-(3-(Trifluoromethyl)phenyl)piperazin-1-yl)pyrrolidin-2-yl)-(3,3-difluoropyrrolidin-1-yl)-methanone dihydrochloride; dipeptidyl peptidase-IV inhibitor; diabetic complications including diabetic neuropathy, diabetic nephropathy, diabetic microangiopathy
04/13/2006US20060079466 Rapamycin carbohydrate derivatives
04/13/2006US20060078980 Production of polyketides and other natural products
04/13/2006US20060078969 Regulated transcription of targeted genes and other biological events
04/13/2006DE4442291B4 Triphendioxazin-Verbindungen Triphendioxazine compounds
04/13/2006DE102004023635A1 Heteroarylsubstituierte Cyclohexyl-1,4-diamin-Derivate Heteroaryl-cyclohexyl-1,4-diamine derivatives
04/13/2006CA2577011A1 Cci-779 derivatives and methods of making same
04/12/2006EP1644392A1 Rapamycin carbohydrate derivatives
04/12/2006EP1644375A2 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
04/12/2006EP1644367A1 Immunosuppressant compounds and compositions
04/12/2006EP1644343A1 5-substituted quinazolinone derivatives
04/12/2006EP1643998A1 Dual nk1/nk3 antagonists for treating schizophrenia
04/12/2006EP1546151B1 Antidepressant cycloalkylamine derivatives of heterocycle-fused benzodioxans
04/12/2006EP1389213B1 3,7-diazabicyclo 3.3.1| formulations as antiarhythmic compounds
04/12/2006EP1005356B1 Novel antibacterial agents
04/12/2006CN1759118A Diazepinoindole derivatives as kinase inhibitors
04/12/2006CN1759116A Pyridyloxymethyl and benzisoxazole azabicyclic derivatives
04/12/2006CN1757645A Material contg. thiophene spirane structure, its synthesis and application
04/12/2006CN1250544C Pyridoarylphenyl oxazolidinone antibacterials and related compositions and methods
04/11/2006US7026331 Inhibitors of IkB kinase (I Kappa B Kinase); treating various diseases including asthma, osteoarthritis, rheumatoid arthritis, Alzheimer's disease, cancer, infections, and cardiac infarct
04/11/2006US7026309 Fused bicyclic pyridine derivative as tachykinin receptor antagonist
04/11/2006US7025975 Galenical formulations
04/06/2006US20060074242 Rapid resolution process of clopidogrel base and a process for preparation of clopidogrel bisulfate polymorph-form I
04/06/2006US20060074125 Novel dithiolopyrrolones with therapeutic activity
04/06/2006US20060074102 Kinase inhibitors as therapeutic agents
04/06/2006US20060074089 Quinolone analogs
04/06/2006DE102004047269A1 New protein or peptide involved in biosynthesis of lysolipins, useful for preparing lysolipin antibiotics in transformed cells
04/06/2006DE102004046142A1 New lydiamycin cyclodepsipeptides useful for controlling diseases cause by mycobacteria, e.g. tuberculosis and leprosy
04/06/2006CA2581747A1 Process for preparing bicyclic pyrazolyl compounds
04/05/2006CN1754880A Process for preparing 2-iminopyrrolidine derivatives
04/04/2006US7022869 Methods of asymmetrically synthesizing enantiomers of casodex, its derivatives and intermediates thereof
04/04/2006US7022850 Bicyclicpyrimidones and their use to treat diseases
04/04/2006US7022849 Quinazoline and pyrido[2,3-d]pyrimidine inhibitors of phosphodiesterase (PDE) 7
04/04/2006US7022720 Synthetic diazonamides as novel anti-mitotic agents
03/2006
03/30/2006WO2006034511A1 Piperidinylamino-thieno[2,3-d] pyrimidine compounds
03/30/2006WO2005113536A3 Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands
03/30/2006WO2005081960A3 Inhibitors of protein tyrosine phosphatase 1b
03/30/2006WO2004113330A8 Immunosuppressant compounds and compositions
03/30/2006US20060069266 Reacting a bis-(beta hydroxyl)amine with a hydroxyl acid, hydroxyl ester or lactone to form a hydroxy amide acetal
03/30/2006US20060069116 3-Amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
03/30/2006US20060069092 Pharmaceutical compositions for the treatment of diseases related to neurotrophines